IFI-M · HPB Tri-Axis Balanced Series

Specimen SS-F-M3-00223 // MULTI-AXIS · IFI-M

HPB Tri-Axis Balanced Series V-PR

Capsicum chinense

Habanero

Tier VHPB Tri-Axis Balanced Series

Target Trait

2.5×

fold-change

Heat+Sharp+Bitter-Attenuation balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-00223

Genomic Edits

12

GC Content

48.9%

Construct Length

6,582 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPV1 + TRPA1 + TAS2R38 (suppression)

IFI Score

250

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • TRPA1 pathway primary gene cluster for sharp (IFI-P) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HPB pathway operation
  • Cross-pathway regulatory circuit for balanced HPB triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPV1, TRPA1, and TAS2R38 (suppression) pathways simultaneously engineeredBalanced tri-axis expression strategy (HPB) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier V HPB triple-axis construct for advanced multi-modal sensory architecture combining heat, sharp, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$9999 · Tier V License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?